arbekacin has been researched along with amikacin in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (30.00) | 18.7374 |
1990's | 1 (5.00) | 18.2507 |
2000's | 7 (35.00) | 29.6817 |
2010's | 6 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, J; de Oliveira Garcia, D; Doi, Y; Paterson, DL | 1 |
Arakawa, Y; Ike, Y; Kimura, K; Kurokawa, H; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
Aggen, JB; Armstrong, ES; Bonomo, RA; Choudhary, Y; Endimiani, A; Hujer, AM; Hujer, KM | 1 |
Brown, JM; Gonoi, T; Ishikawa, J; Kogure, T; Mikami, Y; Shimada, R; Yazawa, K | 1 |
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ | 1 |
Ariga, H; Tanaka, N; Yamaki, H | 1 |
Fillastre, JP; Morin, JP; Olier, B; Thomas, N | 1 |
Hara, K; Hayashi, T; Masuyama, Y; Oda, T; Saito, A; Shigeno, Y; Taira, K; Tomita, H; Yamaguchi, K | 1 |
Coude du Foresto, B; Courtieu, AL; Derriennic, M; Reynaud, AE | 1 |
Kai, F; Kurebe, M; Mitsuhashi, S; Niizato, T; Okamoto, R; Yokota, M; Yoshida, T | 1 |
Bouanchaud, DH; Rolin, O | 1 |
Matsuno, T; Shitara, T; Tsuchiya, T; Umemura, E | 1 |
Abe, T; Fujimura, S; Gomi, K; Kobayashi, T; Nukiwa, T; Takahashi, H; Tokue, Y; Watanabe, A | 1 |
Hirano, M; Katayama, S; Kawada, K; Momose, Y; Nishizawa, K; Takehira, R; Yamamura, S | 1 |
Udou, T | 1 |
Araoka, H; Baba, M; Ishii, Y; Mitsuda, T; Mori, S; Moriya, K; Nakamori, Y; Oguri, T; Ohmagari, N; Oishi, T; Okuzumi, K; Tateda, K; Yamaguchi, K; Yoneyama, A | 1 |
Farrell, DJ; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
Hasegawa, H; Izumikawa, K; Kaku, N; Kosai, K; Miyazaki, T; Morinaga, Y; Mukae, H; Takeda, K; Uno, N; Yanagihara, K | 1 |
Fujita, J; Kirikae, T; Nakasone, I; Shimada, K; Sonozaki, T; Tada, T; Uechi, K | 1 |
1 trial(s) available for arbekacin and amikacin
Article | Year |
---|---|
[Comparative clinical trial of HBK and amikacin (AMK) in the treatment of respiratory infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Dibekacin; Double-Blind Method; Female; Humans; Kanamycin; Male; Middle Aged; Respiratory Tract Infections | 1987 |
19 other study(ies) available for arbekacin and amikacin
Article | Year |
---|---|
Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.
Topics: Amino Acid Sequence; Aminoglycosides; beta-Lactamases; Brazil; Carbapenems; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
Topics: Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Methyltransferases; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Plasmids; Protein Binding; Ribosome Subunits, Small; RNA, Ribosomal, 16S; Sequence Homology, Amino Acid | 2007 |
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure | 2009 |
Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Base Sequence; Canada; Cattle; DNA Primers; Drug Resistance, Bacterial; Female; Genes, Bacterial; Homozygote; In Vitro Techniques; Mastitis, Bovine; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 16S | 2010 |
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare | 2010 |
Inhibition of SV40 DNA replication in vitro by 1-N-acyl-3"-N-(trifluoroacetyl) kanamycin.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Antiviral Agents; Aphidicolin; Deoxycytidine Monophosphate; Dibekacin; Diterpenes; DNA Replication; DNA, Viral; Haplorhini; Hygromycin B; Kanamycin; Nalidixic Acid; Novobiocin; Simian virus 40; Spectrophotometry; Streptomycin | 1986 |
[Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Female; Gentamicins; Kanamycin; Kidney Cortex; Kidney Diseases; Netilmicin; Rats; Rats, Inbred Strains | 1988 |
[Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1988 |
Antibacterial activity and ototoxicity in guinea pigs, and nephrotoxicity in rats of arbekacin.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Dibekacin; Drug Resistance, Microbial; Ear, Inner; Guinea Pigs; Injections, Intramuscular; Kanamycin; Kidney; Male; Rats; Rats, Inbred Strains; Reflex; Structure-Activity Relationship | 1986 |
Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Enterobacteriaceae Infections; Female; Gentamicins; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Sepsis; Tobramycin | 1986 |
Synthesis of 5-deoxy-5-epifluoro derivatives of arbekacin, amikacin, and 1-N-[(S)-4-amino-2-hydroxybutanoyl]tobramycin (study on structure--toxicity relationships).
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Carbohydrate Conformation; Carbohydrate Sequence; Dibekacin; Fluorine Compounds; Mice; Molecular Sequence Data; Tobramycin | 1995 |
Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus | 2000 |
Application of artificial neural network modelling to identify severely ill patients whose aminoglycoside concentrations are likely to fall below therapeutic concentrations.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Artificial Intelligence; Dibekacin; Humans; Intensive Care Units; Logistic Models; Neural Networks, Computer; Predictive Value of Tests; Reference Values; Severity of Illness Index | 2003 |
Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.
Topics: Amikacin; Aminoglycosides; Antitubercular Agents; Colony Count, Microbial; Dibekacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Japan; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Mycobacterium tuberculosis; Nocardia asteroides; Nontuberculous Mycobacteria; Prevalence; Streptomycin; Tobramycin | 2006 |
In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Dibekacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Statistics, Nonparametric | 2012 |
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.
Topics: Amikacin; Anti-Bacterial Agents; Dibekacin; Enterobacter; Humans; Klebsiella; Microbial Sensitivity Tests; Pneumonia; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2015 |
Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Dibekacin; Disease Models, Animal; Drug Compounding; Lung; Mice; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Emergence of ArmA, a 16S rRNA methylase in highly aminoglycoside-resistant clinical isolates of Klebsiella pneumoniae and Klebsiella oxytoca in Okinawa, Japan.
Topics: Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Japan; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Whole Genome Sequencing | 2018 |